Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.505 EUR | -3.53% | +3.08% | -62.38% |
Sales 2023 * | 888K 957K | Sales 2024 * | 653K 704K | Capitalization | 42.51M 45.79M |
---|---|---|---|---|---|
Net income 2023 * | -31M -33.4M | Net income 2024 * | -23M -24.78M | EV / Sales 2023 * | 61.2 x |
Net Debt 2023 * | 11.85M 12.77M | Net Debt 2024 * | 29.45M 31.73M | EV / Sales 2024 * | 110 x |
P/E ratio 2023 * |
-1.35
x | P/E ratio 2024 * |
-1.5
x | Employees | 70 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 76.56% |
Latest transcript on Sequana Medical N.V.
1 day | -3.53% | ||
1 week | +3.08% | ||
Current month | -37.03% | ||
1 month | -39.80% | ||
3 months | -61.51% | ||
6 months | -50.17% | ||
Current year | -62.38% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 15-12-31 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 22-07-18 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 18-11-07 |
Ids van der Weij
BRD | Director/Board Member | - | Nov. 09 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.505 | -3.53% | 392,609 |
24-03-27 | 1.56 | -3.70% | 137,032 |
24-03-26 | 1.62 | -4.71% | 217,348 |
24-03-25 | 1.7 | +10.03% | 516,687 |
24-03-22 | 1.545 | +5.82% | 387,433 |
Real-time Euronext Bruxelles, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.38% | 45.91M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |